Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

VU0238429

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
The activity of an allosteric agonist of muscarinic M1 receptor, VU0357017, and a positive allosteric modulator (PAM) of M5… Expand
2019
2019
Abstract Recent preclinical studies point to muscarinic and GABAB receptors as novel therapeutic targets for the treatment of… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
Abstract Objective. Muscarinic receptors mediate contraction of the human gallbladder through unclear receptor subtypes. The aim… Expand
2010
2010
This Letter describes a chemical lead optimization campaign directed at VU0238429, the first M(5)-preferring positive allosteric… Expand
2010
2010
This Letter describes a chemical lead optimization campaign directed at VU0238429, the first M(5)-preferring positive allosteric… Expand
Highly Cited
2009
Highly Cited
2009
This report describes the discovery and initial characterization of the first positive allosteric modulator of muscarinic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 5